FIELD: organic and medicinal chemistry.
SUBSTANCE: invention relates to the arglabin derivatives of formulas Ib, Ic, Id, Ie. New compounds that can be used in medicine as targeted antitumor medicinal products with low cytotoxicity towards normal cell lines have been obtained.
EFFECT: obtaining arglabin derivatives with selective cytotoxic effects.
4 cl, 2 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT BASED ON ARGLABIN DERIVATIVE, HAVING SELECTIVE CYTOTOXIC ACTION | 2023 |
|
RU2814259C1 |
AGENT BASED ON ARGLABIN DERIVATIVE, HAVING SELECTIVE CYTOTOXIC ACTION | 2023 |
|
RU2814738C1 |
PHOSPHONIUM SALTS BASED ON ALANTOLACTONE, HAVING ANTI-TUMOUR ACTIVITY, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2818095C1 |
REGULATORS-DERIVATIVES OF STEROIDS, METHODS OF THEIR OBTAINING AND THEIR USE | 2019 |
|
RU2797408C2 |
SPIRO DERIVATIVES OF PARTHENIN AS NOVEL ANTICANCER AGENTS | 2009 |
|
RU2499798C2 |
ANTIBODY DRUG CONJUGATES | 2014 |
|
RU2669812C2 |
PHOSPHONIUM SALTS BASED ON BETULINIC ACID GLYCOSIDES WITH ANTITUMOR ACTIVITY | 2022 |
|
RU2803739C1 |
TRIPHENYLPHOSPHONIUM SALTS OF LUPANE TRITERPERNOIDS, METHOD FOR PRODUCING AND USING AS ANTICANCER AGENTS | 2012 |
|
RU2551647C2 |
TREATING OR PREVENTING PROLIFERATIVE CONDITIONS | 2010 |
|
RU2705548C2 |
METHYL-3-ARYL-3A-NITRO-4-(TRIFLUOROMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCHROMENO[3,4-C]PYRROLE-1-CARBOXYLATES, HAVING CYTOTOXIC ACTIVITY ON CELL LINE HUMAN CERVICAL CARCINOMA HELA, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2818191C1 |
Authors
Dates
2023-10-24—Published
2023-02-22—Filed